Cited by 90Probiotics and Fermented FoodsInfant Nutrition and HealthGastrointestinal motility and disorders

Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update

Open access
Szajewska, Hania, Guarino, Alfredo, Hojsak, Iva, Indrio, Flavia, Kolacek, Sanja, Orel, Rok, Salvatore, Silvia, Shamir, Raanan +5 more·2020·Journal of Pediatric Gastroenterology and Nutrition

Abstract

Since the publication of the 2014 European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Working Group (WG) on Probiotics and Prebiotics guidelines for the management of acute gastroenteritis (AGE), new evidence concerning the efficacy of probiotics has become available. This document provides updated recommendations on the use of probiotics for the treatment of AGE in previously presumed healthy infants and children. A systematic literature search was performed. All pooled analyses were explicitly performed for the current report. The WG graded the recommendations and assessed the certainty of the supporting evidence using the Grading of Recommendations, Assessment Development, and Evaluations tool. The recommendations were formulated if at least 2 randomized controlled trials that used a given probiotic were available. Despite the large number of identified trials, the WG could not identify 2 randomized controlled trial of high quality for any strain that provided benefit when used for treating AGE. The WG made weak recommendations for (in descending order in terms of the number of trials evaluating any given strain): Saccharomyces boulardii (low to very low certainty of evidence); Lactobacillus rhamnosus GG (very low certainty of evidence); L reuteri DSM 17938 (low to very low certainty of evidence); and L rhamnosus 19070-2 and L reuteri DSM 12246 (very low certainty of evidence). The WG made a strong recommendation against L helveticus R0052 and L rhamnosus R0011 (moderate certainty of evidence) and a weak recommendation against Bacillus clausii strains O/C, SIN, N/R, and T (very low certainty of evidence).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mpg.0000000000002751

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among viral indications, probiotics have been most extensively studied in the management of viral diarrhea and upper respiratory tract infections, and generally the evidence supporting their efficacy and safety is positive.

    “Among these indications probiotics have been most extensively studied in the management of viral diarrhea (Szajewska et al., 2020) and URTIs (Hao et al., 2015) and, generally, the evidence supporting their efficacy and safety are positive.”

    From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Szajewska et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics con- sensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-14.
  2. Salari P, Nikfar S, Abdollahi M. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy Drug Targets 2012;11:3-14.
  3. Dinleyici EC, Eren M, Ozen M, et al. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012;12:395-410.
  4. Kowalska-Duplaga K, Fyderek K, Szajewska H, et al. Efficacy of Trilac1 in the treatment of acute diarrhoea in infants and young children-a multicentre, randomized, double-blind placebo-controlled study. Pediatria Wspolczesna 2004;6:295-9.
  5. Sugita T, Togawa M. Efficacy of Lactobacillus preparation bioloactis powder in children with rotavirus enteritis. Japan J Pediatr 1994;47:2755-62.
  6. Manyal AK, Phadke VD. Role of probiotic Lactobacillus sporogenes in the treatment of acute diarrhoea in children. Int J Pharm Sci Res 2015;6:767-71.
  7. Szymanski H, Szajewska H. Lack of efficacy of Lactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis: a randomized controlled trial. Pediatr Infect Dis J 2019;38:e237-42.
  8. Tlaskal P, Schramlova J, Kokesova A, et al. Probiotics in the treatment of diarrheal disease of viral etiology in children. NAFAS 2005;3: 25-8.
  9. Lahiri K, Dsouza J, Gahlowt P. Beneficial role of probiotic in acute childhood diarrhoea. J Harmony Res Med And Hlth Sci 2015;2:26-30.

Cited by

Sorted by citations

Authors
Szajewska, H., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Salvatore, S., Shamir, R., van Goudoever, J. B., Vandenplas, Y., Weizman, Z., Zalewski, B. M., & Working Group on Probiotics and Prebiotics of the European Society for Paediatric Gastroenterology, H. A. N.
Affiliations
  • Medical University of Warsaw (PL)
  • Federico II University Hospital (IT)
  • University of Zagreb (HR)
  • Ospedale Pediatrico Giovanni XXIII (IT)
  • Children's Hospital Zagreb, University of Zagreb School of Medicine University J.J. Strossmayer School of Medicine Osijek Croatia
  • Ljubljana University Medical Centre (SI)
  • University of Insubria (IT)
  • Tel Aviv University (IL)
  • Amsterdam UMC, University of Amsterdam and Vrije Universiteit Amsterdam Emma Children's Hospital Paediatrics Amsterdam The Netherlands
  • Vrije Universiteit Brussel (BE)
  • Ben-Gurion University of the Negev (IL)
Corresponding author
  • Szajewska, Hania
  • Zalewski, Bartłomiej M.
Venue
Journal of Pediatric Gastroenterology and Nutrition
Publisher
Wiley
Published
2020-04-28
Volume
71
Issue
2
Pages
261-269
ISSN
  • 0277-2116 (ISSN-L)
  • 1536-4801
OpenAlex
W3018540606
Cited by
90
References
79
Citations by year
2026: 7 · 2025: 12 · 2024: 15 · 2023: 15 · 2022: 22 · 2021: 15 · 2020: 4
FWCI
9.08
Type
journal article
Language
en
Open access
Locations
  • Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • IrInSubria (University of Insubria) (submittedVersion)
  • AIRUS (submittedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
probiotics, acute gastroenteritis, children, infants, Saccharomyces boulardii, Lactobacillus rhamnosus GG, Lactobacillus reuteri, Lactobacillus helveticus, Bacillus clausii, treatment guidelines, quality of evidence
MeSH terms
Child, Diarrhea, Gastroenteritis, Humans, Infant, Practice Guidelines as Topic, Probiotics, Limosilactobacillus reuteri, Lacticaseibacillus rhamnosus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review